Caron Philippe, Maiza Jean Christophe, Renaud Claire, Cormier Catherine, Barres Béatrice Herbault, Souberbielle Jean Claude
Department of Endocrinology and Metabolic diseases, CHU Larrey, Toulouse, Cedex, France.
Clin Endocrinol (Oxf). 2009 Apr;70(4):533-8. doi: 10.1111/j.1365-2265.2008.03408.x.
Primary hyperparathyroidism (PHP) is caused by parathyroid adenomas or hyperplasia, and occasionally by parathyroid carcinoma. Recently a high third generation/second generation PTH ratio has been observed in some patients with parathyroid carcinoma.
We report the case of a 60-year old woman who was presented a fourth episode of PTH-related hypercalcaemia due to a parathyroid carcinoma. Serum PTH levels were measured using a second generation assay and a third generation assay before, 4 and 7 months after the fourth surgery. Then, PTH levels were measured in 294 osteoporotic normocalcaemic patients as well as in 30 consecutive PHP patients.
Before surgery of the patient with parathyroid carcinoma, second generation PTH was 229 pg/ml, third generation PTH was 675 pg/ml and third generation/second generation PTH ratio was 2.95. Four and 7 months after surgery the third generation/second generation PTH ratio was 0.70 and 0.66, respectively. All osteoporotic patients had a normal third generation/second generation PTH ratio (0.585 +/- 0.118) whereas only one patient (3.3%) with PHP had a third generation/second generation PTH ratio > 1 (1.54).
A high third generation/second generation PTH ratio could be observed in patients with parathyroid carcinoma, is uncommon in benign PHP and is absent in osteoporotic patients without PHP. Therefore, PTH level can be measured using second and third generation assays in some PHP patients, and a specific surgical protocol for possible parathyroid carcinoma could be discussed in patients with a high third generation/second generation PTH ratio.
原发性甲状旁腺功能亢进症(PHP)由甲状旁腺腺瘤或增生引起,偶尔也由甲状旁腺癌引起。最近,在一些甲状旁腺癌患者中观察到第三代/第二代甲状旁腺激素(PTH)比值升高。
我们报告了一例60岁女性患者,因甲状旁腺癌出现第四次与PTH相关的高钙血症发作。在第四次手术后0、4和7个月,分别使用第二代检测法和第三代检测法测量血清PTH水平。然后,对294例骨质疏松症血钙正常患者以及30例连续性PHP患者进行PTH水平测量。
甲状旁腺癌患者手术前,第二代PTH为229 pg/ml,第三代PTH为675 pg/ml,第三代/第二代PTH比值为2.95。手术后4个月和7个月,第三代/第二代PTH比值分别为0.70和0.66。所有骨质疏松症患者的第三代/第二代PTH比值均正常(0.585±0.118),而只有1例(3.3%)PHP患者的第三代/第二代PTH比值>1(1.54)。
甲状旁腺癌患者可观察到第三代/第二代PTH比值升高,在良性PHP中不常见,在无PHP的骨质疏松症患者中不存在。因此,对于一些PHP患者可使用第二代和第三代检测法测量PTH水平,对于第三代/第二代PTH比值升高的患者可讨论针对可能的甲状旁腺癌的特定手术方案。